Evidence map›Paper›PMID 37222520›Full record

ArticlemBio2023

Inhibition of miR-200b-3p confers broad-spectrum resistance to viral infection by targeting TBK1.

An Fang, Yueming Yuan, Baokuen Sui, Zhihui Wang, Yuan Zhang, Ming Zhou, Huanchun Chen, Zhen F Fu, Ling Zhao

Open access · goldAbstract read
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

An Fang *State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University , Wuhan, China.
Yueming Yuan *State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University , Wuhan, China.
Baokuen SuiState Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University , Wuhan, China.
Zhihui WangState Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University , Wuhan, China.
Yuan ZhangState Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University , Wuhan, China.
Ming ZhouState Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University , Wuhan, China.
Huanchun ChenState Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University , Wuhan, China.
Zhen F FuState Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University , Wuhan, China.
Ling ZhaoState Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University , Wuhan, China.ORCID 0000-0003-0569-8105
Huazhong Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The host innate immune system's defense against viral infections depends heavily on type I interferon (IFN-I) production. Research into the mechanisms of virus-host interactions is essential for developing novel antiviral therapies. In this study, we compared the effect of the five members of the microRNA-200 (miR-200) family on IFN-I production during viral infection and found that miR-200b-3p displayed the most pronounced regulatory effect. During viral infection, we discovered that the transcriptional level of microRNA-200b-3p (miR-200b-3p) increased with the infection of influenza virus (IAV) and vesicular stomatitis virus (VSV), and miR-200b-3p production was modulated by the activation of the ERK and p38 pathways. We identified cAMP response element binding protein (CREB) as a novel transcription factor that binds to the miR-200b-3p promoter. MiR-200b-3p reduces NF-κB and IRF3-mediated IFN-I production by targeting the 3' untranslated region (3' UTR) of TBK1 mRNA. Applying miR-200b-3p inhibitor enhances IFN-I production in IAV and VSV-infected mouse models, thus inhibiting viral replication and improving mouse survival ratio. Importantly, in addition to IAV and VSV, miR-200b-3p inhibitors exhibited potent antiviral effects against multiple pathogenic viruses threatening human health worldwide. Overall, our study suggests that miR-200b-3p might be a potential therapeutic target for broad-spectrum antiviral therapy. IMPORTANCE The innate immune response mediated by type I interferon (IFN-I) is essential for controlling viral replication. MicroRNAs (miRNAs) have been found to regulate the IFN signaling pathway. In this study, we describe a novel function of miRNA-200b-3p in negatively regulating IFN-I production during viral infection. miRNA-200b-3p was upregulated by the MAPK pathway activated by IAV and VSV infection. The binding of miRNA-200b-3p to the 3' UTR of TBK1 mRNA reduced IFN-I activation mediated by IRF3 and NF-κB. Application of miR-200b-3p inhibitors exhibited potent antiviral effects against multiple RNA and DNA viruses. These results provide fresh insight into understanding the impact of miRNAs on host-virus interactions and reveal a potential therapeutic target for common antiviral intervention.

Indexed as

Interferon Type IMicroRNAsVirus Diseases3' Untranslated RegionsAnimalsAntiviral AgentsHumansMiceNF-kappa BProtein Serine-Threonine KinasesVirus Replication3' Untranslated RegionsAntiviral AgentsInterferon Type IMicroRNAsMIRN200 microRNA, humanNF-kappa BProtein Serine-Threonine KinasesTBK1 protein, humanbroad-spectruminfluenza virusinnate immunityinterferonmicroRNA-200b-3pTBK1viral infection

Identifiers

PMID37222520
PMCPMC10470528
OpenAlexW4377940960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.